ER+ breast cancer cell lines are known to be more susceptible to serine depletion, probably due to lack of amplification of phosphoglycerate dehydrogenase, and thus are less addicted to serine metabolism compared with ER− tumors (49, 50). Here, ESR1 is linked to breast carcinoma.